Director Early Phase ResearchMAC Clinical Research, England, United Kingdom
Disclosure information not submitted.
Phase 1 Study of the Safety and Pharmacokinetics of CSL889 (Hemopexin) in Adults with SCD
Saturday, June 8, 20249:00 AM - 9:15 AM ET